Nasdaq GlobeNewswire

Global Survey Released by ISAPS Reports Increase of Over One Million Cosmetic and Aesthetic Procedures Performed in 2015

Del

NEW YORK, 2016-07-26 10:00 CEST (GLOBE NEWSWIRE) -- The worldwide reach of the International Society of Aesthetic Plastic Surgery (ISAPS) is well known to the global plastic and aesthetic surgery community.  Now the release of eagerly awaited procedural survey results shows an increase of over one million reported procedures from 2014 to 2015.

The data on surgical and non-surgical treatments performed in 2015 was tabulated from a questionnaire sent to approximately 35,000 plastic surgeons in the proprietary ISAPS database. ISAPS is the only organization that collects this type of data on a global scale and the study is viewed as a valuable resource in the field of aesthetics.

Of course the most awaited features of the survey are the most popular types of procedures in the world by country. Botulinum Toxin (BOTOX®) continues to reign supreme for both men and women with a total of over 4.6 million procedures reported.  Another popular injectable, Hyaluronic Acid, increased 6.5% from 2014 to 2015.  Breast augmentation continues to be the most common surgical procedure among women with a 10.4% increase from 2014 while eyelid surgery is prevalent among men.  

Most Popular Surgical Procedures in 2015:

Procedure 2015 2014 Percentage
Breast Augmentation 1,488,992 1,348,197   10.4 %
Liposuction 1,394,588 1,372,901   1.6 %
Eyelid Surgery 1,264,702 1,427,451   -11.4 %
Abdominoplasty 758,590 682,568   11.1 %
           

Most Popular Non-Surgical Procedures in 2015:

Procedure 2015 2014 Percentage
Botox 4,627,752 4,830,911   -4.2 %
Hyaluronic Acid 2,865,086 2,690,633   6.5 %
Hair Removal 1,099,053 1,277,581   -14.0 %
Photo Rejuvenation 568,672 -   -  
Non-Surgical Fat Reduction  425,315 -   -  
           

“We are proud to share these survey results to show the growing momentum in highly practiced areas,” noted Susumu Takayanagi, MD, ISAPS president. “ISAPS’ membership includes thousands of top plastic surgeons who take time to contribute to these findings,” he states.   The results can be accessed on the ISAPS website http://www.isaps.org in the News section, and will be discussed during the 23rd ISAPS biennial global conference in Kyoto, Japan, October 23-27, 2016.

The country with the highest number of procedures is the United States with 1.4 million surgical and 2.6 million non-surgical procedures.  Brazil reported 1.2 million surgical and 1.1 million non-surgical procedures.  Rounding out the list for the most procedures are South Korea, India, Mexico, Germany, Colombia, France, and Italy. 

The United States has the largest number of active plastic surgeons with 6,500 followed by Brazil with 5,500 and China with 2,800.  Numbers by country are evidenced in the report; however, some countries did not provide required updates this year.

Women had more than 18 million surgical and non-surgical procedures performed globally, 85.6% of the total. The top five surgical procedures performed on women in 2015 were: breast augmentation, liposuction, eyelid surgery, abdominoplasty and rhinoplasty.

Men had more than 3 million surgical and non-surgical procedures, 14.4% of the total. The top five surgical procedures performed on men were: eyelid surgery, liposuction, gynecomastia surgery, rhinoplasty, fat grafting and ear surgery.

The International Survey on Aesthetic/Cosmetic Procedures Performed in 2015 was compiled, tabulated, and analyzed by Industry Insights, Inc. http://www.industryinsights.com, an independent research firm based in Columbus, OH.

About ISAPS:
The International Society of Aesthetic Plastic Surgery is the premier global organization for board certified (or the equivalent) plastic surgeons. Regarded as the leading global educator in aesthetic procedures, ISAPS offers its more than 3,200 members over 30 courses, workshops and symposia each year conducted by a world-class faculty with the primary goal of teaching aesthetic best practices and ensuring patient safety. Through its rigorous membership screening, ISAPS is a guardian of patient safety internationally, making it the patient's global resource to find qualified and experienced aesthetic plastic surgeons.

         Media Contact:
         Julie Guest, ISAPS Chief Marketing Officer
         Media@ISAPS.org
         1-844-867-3621

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

GlobeNewswire Test Release26.5.2018 07:00Pressemelding

LOS ANGELES, May 25, 2018 (GLOBE NEWSWIRE) -- This is a test from GlobeNewswire. Readers are advised to disregard. TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING -- TESTING – -END- CONTACT: Karen Yu Director, GlobeNewswire Product Management Direct: +1 310 258 6917 Mobile: +1 626 389 7427 or Magali Rolandez Senior Manager, Media Relations/Content Distribution Europe Direct: +44 (0) 203 753 2215 Mobile: +44 (0) 7785 619 539

Medibio Corporate Health Extends Global Footprint Signing Contract with Jacobs Engineering25.5.2018 16:38Pressemelding

Jacobs, one of the world's largest engineering and environmental consultancy groups, has more than 70,000 employees globally SYDNEY, Australia and MINNEAPOLIS, May 25, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a mental health technology company, today announced a significant contract for Medibio's Corporate Health product with Dallas, TX-based Jacobs Engineering across their Asia Pacific, Middle East, and European divisions. Through the Mental Health Check-In, companies can offer employees an end-to-end mental health program, direct to their devices, to see how the mind and body are tracking. It's a personalized, private, and objective way to see the unseeable: mental health issues in the workplace. Employees are provided the opportunity to confidentially check-in on their mental health and receive personalized confidential results from both an objective biometric screening in conjunction with a 12-minute subjective survey. Employers receive

VIRGIN PULSE ANNOUNCES INDUSTRY-LEADING GDPR COMPLIANCE25.5.2018 14:00Pressemelding

Virgin Pulse Extends the GDPR's Strong Data Privacy Rights to All Clients and Members Across the Globe PROVIDENCE, R.I., May 25, 2018 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of digital employee health, wellbeing and engagement solutions, today announced that it has achieved compliance with the EU General Data Protection Regulation (GDPR) for the Virgin Pulse platform. The company has also appointed Associate Counsel Beatrice Botti as Data Protection Officer (DPO) to oversee the Virgin Pulse privacy program. With this achievement, Virgin Pulse leads the market as the first company in the wellbeing and engagement industry to fully meet the comprehensive standards of the new GDPR data privacy law. The company has completed a thorough review of its internal data collection, storage and handling processes and implemented enhancements to achieve GDPR compliance and give all Virgin Pulse customers and members greater control over their personal data. The GDPR is the firs

Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress25.5.2018 07:45Pressemelding

CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?" The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascular disease, especially in patients with diabetes mellitus, and the significant unmet need that still exists in this patient population. The symposium is co-chaired by Vincent M. Brandenburg, MD - Nephrologist, Aachen, Germany and Kamyar Kalantar-Zadeh, MD - UC Irvine School of Medicine, Irvine, CA, USA, both leading scientists also serving as advisors to Resverlogix's Renal program. The speakers and agenda are as follows: Introduction Vincent M. Brandenburg, MD - University Hospital of the RWTH

Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30Pressemelding

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional

Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16Pressemelding

London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom